BridgeMD
Ketamine for depression and alcohol use disorder
EU CTIS ID: 2023-506052-24-00
What this study is testing
The primary objective is to assess the efficacy of ketamine for depression in adults with depression and AUD that are admitted for addiction therapy
- Phase I and Phase II (Integrated)- Other
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 18-65 years of age
- At least moderate depression without psychotic features
- Alcohol dependence as their primary substance use disorder
- Must be admitted to the hospital for inpatient addiction therapy at one of the inpatient units at University Hospital of North Norway
You likely can't join if
- Not able to provide adequate informed consent
- Illegal use of ketamine the last 6 months
- Current or past history of psychotic disorder
- Significant cardiovascular event during the last year
- Liver failure or impariment of liver function
- Significant chronic kidney failure
See the full eligibility criteria
- 18-65 years of age
- At least moderate depression without psychotic features
- Alcohol dependence as their primary substance use disorder
- Must be admitted to the hospital for inpatient addiction therapy at one of the inpatient units at University Hospital of North Norway
- Not able to provide adequate informed consent
- Illegal use of ketamine the last 6 months
- Current or past history of psychotic disorder
- Significant cardiovascular event during the last year
- Liver failure or impariment of liver function
- Significant chronic kidney failure
- Significant chronic heart failure
- Significant chronic respiratory failure
- Previous anaphylactic reaction to the IMP or AMP
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.